Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

An update on insertable cardiac monitors: examining the latest clinical evidence and technology for arrhythmia management

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Efficacy of carvedilol in pediatric heart failure

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Hormone therapy and cardiovascular risk markers and disease: focus on progestagens

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Level of Physical Activity, Left Ventricular Mass, Hypertension, and Prognosis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Catheter ablation for atrial fibrillation is associated with lower incidence of heart failure and death

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Continuous cardiac rhythm monitoring has undergone compelling progress over the past decades. Cardiac monitoring has emerged from 12-lead electrocardiograms being performed at the discretion of the treating physician to in-hospital telemetry, Holter monitoring, prolonged external event monitoring and most recently toward insertable device monitoring for several years. Significant advantages and disadvantages pertaining to these monitoring options will be addressed in this review. Insertable cardiac monitors have several advantages over external monitoring techniques and may signify a clinical turning point in the field of arrhythmia management. However, their role in the detection of paroxysmal atrial fibrillation after cryptogenic strokes has yet to evolve. This will be the main focus of this review. Issues surrounding patient selection, clinical relevance and determination of cost-effectiveness for prolonged cardiac monitoring require further studies. Furthermore, insertable cardiac monitoring has not only the potential to augment diagnostic capabilities but also to improve the management of paroxysmal atrial fibrillation.

OriginalsprogEngelsk
TidsskriftFuture Cardiology
Vol/bind11
Udgave nummer3
Sider (fra-til)333-46
Antal sider14
ISSN1479-6678
DOI
StatusUdgivet - maj 2015

ID: 45517580